Imaging in lung cancer

Current Opinion in Pulmonary Medicine

Volumn 2, Issue 4, 1996, Pages 263-270

  Sarinas, Priscilla S A ^a,b   Chitkara, Rajinder K ^a,b   Rizk, Norman W ^a,b   Segall, George M ^a,b   Stark, Paul ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FOLLOW UP; HUMAN; LUNG TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY; REVIEW; SCINTISCANNING; THORAX RADIOGRAPHY;

DIAGNOSTIC IMAGING; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; RADIOGRAPHY, THORACIC; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030178562     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF Jr: Smoking and cancer mortality among US veterans: a 26 year follow-up. Int J Cancer 1995, 60:190-195.
2. Travis WD, Travis LB, Devesa SS: Lung cancer. Cancer 1995, 75:191-202.
3. Colby TV, Koss MN, Travis WD: Carcinoma of the lung: overview, incidence, etiology, and screening. In Tumors of the Lower Respiratory Tract, edn 3. Washington, DC: Armed Forces Institute of Pathology; 1995:91-106. [Atlas of Tumor Pathology, vol 13.] This is a complete review of the epidemiology of lung cancer.
4. Colby TV, Koss MN, Travis WD: Carcinoma of the lung: overview, incidence, etiology, and screening. In Tumors of the Lower Respiratory Tract, edn 3. Washington, DC: Armed Forces Institute of Pathology; 1995:91-106. [Atlas of Tumor Pathology, vol 13.] This is a complete review of the epidemiology of lung cancer.
5. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA Cancer J Clin 1995, 45:8-30.
6. Ballinger JR: Radiologic imaging in cancer. Med Clin North Am 1996, 80:201-218.
7. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 1996, 46:5-27.
8. Batra P, Brown K, Aberle DR, Young DA, Steckel R: Imaging techniques in the evaluation of pulmonary parenchymal neoplasms. Chest 1992, 101:239-243.
9. Glazer HS, Muka E, Sagel SS, Jost RG: New techniques in chest radiography. Radiol Clin North Am 1994, 32:711-729. A comprehensive summary of conventional chest radiography and advances in screen-film technology, beam-equalization radiography, and digital chest radiography.
10. Colby TV, Koss MN, Travis WD: Carcinoma of the lung: clinical and radiographic aspects, spread, staging, management, and prognosis. In Tumors of the Lower Respiratory Tract, 3rd series edn. Washington, DC: Armed Forces Institute of Pathology; 1995:107-134. [Atlas of Tumor Pathology, vol 13.] A detailed review of the clinical, radiographic, and histopathologic correlation of lung cancer.
11. Colby TV, Koss MN, Travis WD: Carcinoma of the lung: clinical and radiographic aspects, spread, staging, management, and prognosis. In Tumors of the Lower Respiratory Tract, 3rd series edn. Washington, DC: Armed Forces Institute of Pathology; 1995:107-134. [Atlas of Tumor Pathology, vol 13.] A detailed review of the clinical, radiographic, and histopathologic correlation of lung cancer.
12. Pugatch RB: Radiologic evaluation in chest malignancies: a review of imaging modalities. Chest 1995, 107(6 suppl):294S-297S. This key reference addresses the radiographic characterization of SPN the current role of CT and MRI in mediastinal evaluation, and the use of extrathoracic imaging in patient with non-small cell lung cancer.
13. Correa J, Souto M, Tahoces PG, Malagari KS, Tucker DM, Larkin JJ, Kuhlman J, Barnes GT, Zerhouni EA, Fraser RG, Vidal JJ: Digital chest radiography: comparison of the unprocessed and processed images in the detection of solitary pulmonary nodules. Radiology 1995, 195:253-258.
14. MacMahon H, Giger M: Portable chest radiography techniques and teleradiology. Radiol Clin North Am 1996, 34:1-20.
15. MacMahon H, Doi K: Digital chest radiography. Clin Chest Med 1991, 12:19-32.
16. Midthun DE, Swensen SJ, Jett JR: Approach to the solitary pulmonary nodule. Mayo Clin Proc 1993, 68:378-385.
17. Lillington GA: Management of the solitary pulmonary nodule. Hosp Prac 1993, 28:41-48.
18. Lillington GA, Caskey CI: Evaluation and management of solitary and multiple pulmonary nodules. Clin Chest Med 1993, 14:111-119.
19. Libby DM, Henschke CI, Yankelevitz DF: The solitary pulmonary nodule: update 1995. Am J Med 1995, 99:491-496.
20. Grover FL: The role of CT and MR in staging of the mediastinum. Chest 1994, 106(6 suppl):391S-396S.
21. Colice GL: Chest CT for known or suspected lung cancer. Chest 1994, 106:1538-1550.
22. Primack SL, Lee KS, Logan PM, Miller RR, Muller NL: Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology 1994, 193:795-800.
23. Stitik FP: The new staging of lung cancer. Radiol Clin North Am 1994, 32:635-647.
24. Quint LE, Francis IR, Wahl RL, Bross BH, Glazer GM: Preoperative staging of non-small-cell carcinoma of the lung: imaging methods. AJR Am J Roentgenol 1995, 164:1349-1359. This comprehensive reference discusses the major imaging techniques used to stage non-small cell lung cancer.
25. Webb WR: Lung cancer staging: the role of imaging. In Lung Cancer. Edited by Johnson BE, Johnson DH. New York: Wiley-Liss; 1995:97-121.
26. Grewal RG, Austin JHM: CT demonstration of calcification in carcinoma of the lung. J Comput Assist Tomogr 1994, 18:867-871.
27. Daly BTD, Faling LJ, Bite G, Gale ME, Bankoff MS, Yangja J-L, Cooper AG, Snider GL: Mediastinal lymph node evaluation by computed tomography in lung cancer. J Thorac Cardiovasc Surg 1987, 94:664-672.
28. Malenka DJ, Colice GL, Beck JR: Does the mediastinum of patients with non-small cell lung cancer require histologic staging? Am Rev Respir Dis 1991, 144:1134-1139.
29. Haramati LB, Cartagena AM, Austin JHM: CT evaluation of mediastinal lymphadenopathy: noncontrast 5 mm vs postcontrast 10 mm sections. J Comput Assist Tomogr 1995, 19:375-378.
30. Swenson SJ, Brown LR, Colby TV, Weaver AL: Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995, 194:393-398.
31. Yamashita K, Matsunobe S, Tsuda T, Nemoto T, Matsumoto K, Miki H, Konishi J: Solitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CT. Radiology 1995, 194:399-405.
32. Naidich DP: Helical computed tomography of the thorax. Radiol Clin North Am 1994, 32:759-774.
33. Touliopoulos P, Costello P: Helical (spiral) CT of the thorax. Radiol Clin North Am 1995, 33:843-861.
34. Seltzer SE, Judy PF, Adams DF, Jacobson FL, Stark P, Kiinis R, Swensson RG, Hooton S, Head B, Feldman U: Spiral CT of the chest: comparison of cine and film-based viewing. Radiology 1995, 197:73-78.
35. Rubin GD, Beaulieu CF, Argiro V, Ringl H, Norbash AM, Feller JF, Dake MD, Jeffrey RB, Napel S: Perspective volume rendering of CT and MR images; application for endoscopic imaging. Radiology 1996, 199:321-330.
36. Vining DJ, Liu K, Choplin RH, Haponik EF: Virtual bronchoscopy: relationships of virtual reality endobronchial simulations to actual bronchoscopic findings. Chest 1996, 109:549-553.
37. Mayo JR: Magnetic resonance imaging of the chest. Radiol Clin North Am 1994, 32:795-809.
38. Mc Loud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JO, Moore EH, Wain JC, Mathisen DJ, Grillo HC: Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992, 182:319-323.
39. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR, McNeil BJ: CT and MR Imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991, 178:705-713.
40. 11C-methionine.
41. Kwekkeboom DJ, Kho GS, Lamberts SW, Reubi J-C, Laissue JA, Krenning EP: The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994, 21:1106-1113.
42. Patz EF, Goodman PC: Positron emission tomography imaging of the thorax. Radiol Clin North Am 1994, 32:811-823. This is a superb review of PET fundamentals, background, technique, and investigations.
43. Chiti A, Grasselli G, Maffioli L, Gasparini M, Infante M, Bombardieri E: Assessment of mediastinal involvement in lung cancer with [99mTc]-sesta mibi spet [abstract]. Eur J Nucl Med 1995, 22:774.
44. 18F-fluorodeoxyglucose PET studies changed the therapeutic strategy in patients with non-small cell lung cancer and changed the therapeutic decisions in as many as 30% of patients.
45. Kubota K, Yamada S, Ishiwata K, Ito M, Ido T: Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer. Eur J Nucl Med 1992, 17:877-881.
46. Kubota K, Yamada S, Ishiwata K, Ito M, Fujiwara T, Fukuda H, Tada M, Ido T: Evaluation of the treatment response of lung cancer with positron emission tomography and L[methyl-11C] methionine: a preliminary study. Eur J Nucl Med 1993, 20:495-501.
47. Duhaylongsod FG, Lowe VJ, Patz EF Jr., Vaughn AL, Coleman RE, Wolfe WG: Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995, 110:130-140.
48. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP: Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: potential role in evaluation and management Chest 1993, 104:997-1002.
49. Patz EF, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, Goodman PC: Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993, 188:487-490.
50. Hubner KF, Buonocore E, Singh SK, Gould HR, Cotten DW: Characterization of chest masses by FDG positron emission tomography. Clin Nucl Med 1995, 20:293-298.
51. Gupta NC, Frank AR, Dewan NA, Redepenning LS, Rothberg ML, Mailliard JA, Phalen JJ, Sunderland JJ, Frick MP: Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992, 184:441-444.
52. Weber W, Romer W, Ziegler S, Schad D, Herz M, Prauer H, Schwaiger M: Clinical value of D-18-FDG PET in solitary pulmonary nodules [abstract]. Eur J Nucl Med 1995, 22:775.
53. Paulus P, Benoit T, Bury T, Bisogni C, Foidart-Wilems J, Depas G, Radermecker MF, Rigo P: Positron emission tomography with 18F-fluorodeoxyglucose in the assessment of solitary pulmonary nodules [abstract]. Eur J Nucl Med 1995, 22:775.
54. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB: Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994, 191:371-377.
55. Chin R Jr., Ward R, Keyes JW, Choplin RH, Reed JC, Wallenhaupt S, Hudspeth AS, Haponik EF Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995, 152:2090-2096.
56. Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, Myers RW, Lutrin CL, Shelton DK, Sutter CW: Staging NSCLC by PET imaging. Ann Thorac Surg 1995, 60:1573-1582.
57. Patz JEF, Lowe VJ, Goodman PC, Herndon J: Thoracic nodal staging with PET imaging with 18-FDG in patients with bronchogenic carcinoma. Chest 1995, 108:1617-1621. This landmark report comparing PET with CT and thoracic nodal mapping suggests that treatment can be based on the extent of disease suggested by PET imaging.
58. Lewis P, Griffin S, Marsden P, Gee T, Nunan T, Malsey M, Dussek J: Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994, 344:1265-1266.
59. Baum R, Rust M, Strassmann G, Berkefeld J, Wagner R, Hertela A, Caspary W, Hoer G: Whole body positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose for preoperative staging of lung cancer: influence on patients' management [abstract]. Eur J Nucl Med 1995, 22:775.
60. Steinert H, Hauser M, Allemann F, Berthold T, Weder W, von Schulthess GK: Non-small cell lung cancer: staging by whole body FDG-PET, CT, and surgical correlation [abstract]. Eur J Nucl Med 1995, 22:775.
61. Patz EF, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC: Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-deoxy-D-glucose. Radiology 1994, 191:379-382.
62. Frank A, Lefkowitz D, Jaeger S, Gobar L, Sunderland J, Gupta N, Scott W, Mailliard J, Lynch H, Bishop J, et al.: Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int J Radiation Oncology Biol Phys 1995, 32:1495-1512.
63. Inoue T, Kim EE, Ritsuko K, Wong FCL, Bassa P, Wong W-H, Yang DJ, Endo E, Podoloff DA: Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995, 36:788-793.
64. Dewan NA, Reeb SD, Gupta NC, Grobar LS, Scott WJ: PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. Chest 1995, 108:441-446. This important comparative risk-benefit analysis in 33 patients reports PET to be an efficacious noninvasive alternative to transthoracic needle aspiration in the evaluation of lung lesions with a predictive accuracy of 94% and low risk of complications.